RPV-LA (rilpivirine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RPV-LA (rilpivirine), covering 2019-06-13 to 2019-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults [Phase 3]